MI

Mitsubishi Research Institute, Inc.

A think tank providing research, consulting, and ICT solutions to public & private sectors.

3636 | T

Overview

Corporate Details

ISIN(s):
JP3902200009
LEI:
Country:
Japan
Address:
千代田区永田町二丁目10番3号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mitsubishi Research Institute, Inc. (MRI), established in 1970, is a prominent Japanese think tank and consulting firm. As a core member of the Mitsubishi Group, MRI provides integrated services encompassing research, consulting, and ICT solutions to both public and private sector clients. The firm specializes in developing comprehensive solutions to address complex societal and business challenges. MRI leverages its extensive expertise to support clients globally, with significant experience in Asia and the Middle East, aiming to contribute to a prosperous and sustainable society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 06:18
Major Shareholding Notification
変更報告書
Japanese 56.2 KB
2025-06-03 07:27
Major Shareholding Notification
変更報告書
Japanese 54.5 KB
2025-04-25 09:14
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-25 09:12
Interim Report
半期報告書-第56期(2024/10/01-2025/09/30)
Japanese 212.8 KB
2024-12-19 06:02
Regulatory News Service
臨時報告書
Japanese 25.9 KB
2024-12-11 02:25
Registration Form
確認書
Japanese 8.1 KB
2024-12-11 02:24
Governance Information
内部統制報告書-第55期(2023/10/01-2024/09/30)
Japanese 22.3 KB
2024-12-11 02:22
Annual Report
有価証券報告書-第55期(2023/10/01-2024/09/30)
Japanese 2.8 MB
2024-04-26 06:41
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-04-26 06:39
Quarterly Report
四半期報告書-第55期第2四半期(2024/01/01-2024/03/31)
Japanese 212.4 KB
2024-02-06 05:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-02-06 05:30
Quarterly Report
四半期報告書-第55期第1四半期(2023/10/01-2023/12/31)
Japanese 161.5 KB
2023-12-20 06:46
Post-Annual General Meeting Information
臨時報告書
Japanese 28.2 KB
2023-12-19 06:01
Registration Form
確認書
Japanese 8.1 KB
2023-12-19 06:00
Governance Information
内部統制報告書-第54期(2022/10/01-2023/09/30)
Japanese 22.3 KB

Automate Your Workflow. Get a real-time feed of all Mitsubishi Research Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mitsubishi Research Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mitsubishi Research Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.